Compare Suven Life Sciences with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES IPCA LABS SUVEN LIFE SCIENCES/
IPCA LABS
 
P/E (TTM) x -81.4 21.7 - View Chart
P/BV x 1.3 7.8 16.4% View Chart
Dividend Yield % 1.8 0.2 1,153.4%  

Financials

 SUVEN LIFE SCIENCES   IPCA LABS
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
IPCA LABS
Mar-19
SUVEN LIFE SCIENCES/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs3381,042 32.4%   
Low Rs169590 28.7%   
Sales per share (Unadj.) Rs52.1298.6 17.5%  
Earnings per share (Unadj.) Rs6.835.0 19.5%  
Cash flow per share (Unadj.) Rs8.649.4 17.3%  
Dividends per share (Unadj.) Rs1.503.00 50.0%  
Dividend yield (eoy) %0.60.4 160.9%  
Book value per share (Unadj.) Rs65.3247.1 26.4%  
Shares outstanding (eoy) m127.28126.35 100.7%   
Bonus/Rights/Conversions -ESOS-  
Price / Sales ratio x4.92.7 178.0%   
Avg P/E ratio x37.123.3 159.2%  
P/CF ratio (eoy) x29.616.5 179.2%  
Price / Book Value ratio x3.93.3 117.6%  
Dividend payout %22.08.6 256.2%   
Avg Mkt Cap Rs m32,272103,108 31.3%   
No. of employees `0001.113.4 8.0%   
Total wages/salary Rs m6617,874 8.4%   
Avg. sales/employee Rs Th6,132.22,807.0 218.5%   
Avg. wages/employee Rs Th611.1585.8 104.3%   
Avg. net profit/employee Rs Th803.5329.0 244.2%   
INCOME DATA
Net Sales Rs m6,63537,732 17.6%  
Other income Rs m242577 42.0%   
Total revenues Rs m6,87738,309 18.0%   
Gross profit Rs m1,6046,901 23.2%  
Depreciation Rs m2211,824 12.1%   
Interest Rs m38189 20.0%   
Profit before tax Rs m1,5875,465 29.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7181,042 68.9%   
Profit after tax Rs m8694,422 19.7%  
Gross profit margin %24.218.3 132.2%  
Effective tax rate %45.219.1 237.1%   
Net profit margin %13.111.7 111.8%  
BALANCE SHEET DATA
Current assets Rs m6,23223,778 26.2%   
Current liabilities Rs m1,49010,975 13.6%   
Net working cap to sales %71.533.9 210.6%  
Current ratio x4.22.2 193.0%  
Inventory Days Days86104 83.3%  
Debtors Days Days8366 125.3%  
Net fixed assets Rs m4,04320,368 19.9%   
Share capital Rs m127253 50.4%   
"Free" reserves Rs m8,18330,971 26.4%   
Net worth Rs m8,31031,224 26.6%   
Long term debt Rs m181,409 1.3%   
Total assets Rs m10,38945,507 22.8%  
Interest coverage x43.130.0 143.9%   
Debt to equity ratio x00 4.7%  
Sales to assets ratio x0.60.8 77.0%   
Return on assets %8.710.1 86.2%  
Return on equity %10.514.2 73.9%  
Return on capital %19.517.3 112.6%  
Exports to sales %045.9 0.0%   
Imports to sales %016.6 0.0%   
Exports (fob) Rs mNA17,308 0.0%   
Imports (cif) Rs mNA6,266 0.0%   
Fx inflow Rs m5,62217,308 32.5%   
Fx outflow Rs m1,7996,266 28.7%   
Net fx Rs m3,82211,042 34.6%   
CASH FLOW
From Operations Rs m3564,923 7.2%  
From Investments Rs m-279-1,563 17.8%  
From Financial Activity Rs m-225-1,832 12.3%  
Net Cashflow Rs m-1481,528 -9.7%  

Share Holding

Indian Promoters % 63.4 45.9 138.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.4 -  
FIIs % 0.0 25.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.4 209.8%  
Shareholders   37,287 36,892 101.1%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   NATCO PHARMA  PANACEA BIOTECH  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare SUVEN LIFE SCIENCES With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 598 Points Lower, Nifty Settles Below 15,100-Mark; HDFC and JSW Steel Top Losers(Closing)

Indian share markets witnessed huge selling during closing hours today and ended their day deep in the red.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SCIENCES SHARE PRICE


Mar 4, 2021 03:36 PM

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES - WOCKHARDT COMPARISON

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS